Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children

JAMA

Volumn 290, Issue 15, 2003, Pages 2001-2007

  Pui, Ching Hon ^a,b   Sandlund, John T ^a,b   Pei, Deqing ^a   Rivera, Gaston K ^a,b   Howard, Scott C ^a,b   Ribeiro, Raul C ^a,b   Rubnitz, Jeffrey E ^a,b   Razzouk, Bassem I ^a,b   Hudson, Melissa M ^a,b   Cheng, Cheng ^a   Raimondi, Susana C ^a,b   Behm, Frederick G ^a,b   Downing, James R ^a,b   Relling, Mary V ^a,b,c   Evans, William E ^a,b,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DNA; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; CENTRAL NERVOUS SYSTEM; CHILD; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 19; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIPLOIDY; DRUG MEGADOSE; DRUG PULSE THERAPY; E2A PBX1 FUSION GENE; ETHNOLOGY; FEMALE; FOLLOW UP; GENDER; GENE FUSION; HIGH RISK POPULATION; HUMAN; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LEUKEMIC CELL DNA INDEX; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MITOSIS INDEX; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; REMISSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNITED STATES; ACUTE LYMPHOCYTIC LEUKEMIA; GENETICS; INFANT; MORTALITY; PRESCHOOL CHILD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0142024750     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.15.2001     Document Type: Article

References (43)

1. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol. 1991;133:672-682.
2. Howard J, Hankey BF, Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 1992;69:2349-2360.
3. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
4. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
5. Jemal A, Murray T, Samuela A, Ghafoor A, Ward E, Thun MJ. Cancer Statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
6. Walters TR, Bushore M, Simone J. Poor prognosis in Negro children with acute lymphocytic leukemia. Cancer. 1972;29:210-214.
7. Reaman GH, Leikin SL. Racial variation in the frequency of immunological subtypes of childhood acute lymphoblastic leukemia. Prog Cancer Res Ther. 1984;27:163-168.
8. Sather H, Honour R, Sposto R, Level C, Hammon D. Differences in the presentation of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in black children and white children: a report from the Epidemiology Committee of the Children's Cancer Study Group. Prog Cancer Res Ther. 1984;27:179-187.
9. Falletta JM, Boyett J, Pullen DJ, et al. Clinical and phenotypic features of childhood acute lymphocytic leukemia in whites, blacks, and Hispanics: a Pediatric Oncology Group study. Prog Cancer Res Ther. 1984;27:191-195.
10. Kalwinsky DK, Rivera G, Dahl GV, et al. Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome. Leuk Res. 1985;9:817-823.
11. Pinkel D. Ethnicity and survival in children with acute lymphoid leukemia. Leukemia. 1993;7(suppl 2):S146-147.
12. Novakovic B. US childhood cancer survival, 1973-1987. Med Pediatr Oncol. 1994;23:480-486.
13. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1996. Bethesda, Md: National Cancer Institute; 1999.
14. Pui CH, Boyett JM, Hancock ML, et al. Outcome of treatment for childhood cancer in black as compared with white children: The St Jude Children's Research Hospital experience, 1962 through 1992. JAMA. 1995;273:633-637.
15. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605-615.
16. Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program. 1975-1995, National Cancer Institute, SEER Program. Bethesda, Md: National Institutes of Health; 1999: Publication 99-4649.
17. Pollock BH, DeBaun MR, Camitta BM, et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 2000;18:813-823.
18. Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002;100:1957-1964.
19. Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998;92:411-415.
20. Relling MV, Boyett JM, Blanco JG, et al. Granulocyte-colony stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. Blood. 2003;101:3862-3867.
21. Pui CH. Childhood leukemias. N Engl J Med. 1995;332:1618-1630.
22. Gajjar A, Harrison PL, Sandlund JT, et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96:3381-3384.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
24. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980:169.
25. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
26. Agresti A. An introduction to categorical data analysis. New York, NY: John Wiley & Sons Inc; 1996.
27. Howard SC, Gajjar AJ, Cheng C, et al. Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia. JAMA. 2002;288:2001-2007.
28. Pui CH, Williams DL, Kalwinsky DK, et al. Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia. Blood. 1986;67:1688-1692.
29. Pui CH, Williams DL, Roberson PK, et al. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. J Clin Oncol. 1988;6:56-61.
30. Wilson JF, Weale ME, Smith AC, et al. Population genetic structure of variable drug response. Nat Genet. 2001;29:265-269.
31. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. In press.
32. Matherly LH, Taub JW, Wong SC, et al. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Blood. 1997;90:578-589.
33. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia. 2000;14:2286-2294.
34. Schrappe M, Reiter A, Zimmermann M, et al. Longterm results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia. 2000;14:2205-2222.
35. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia. 2000;14:2223-2233.
36. Mahmoud HH, Rivera GK, Hancock ML, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993;329:314-319.
37. Pui CH, Simone JV, Hancock ML, et al. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude Total Therapy Study X. Leukemia. 1992;6:150-157.
38. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia. 2000;14:2267-2275.
39. Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia. 2000;14:2276-2285.
40. Clarke M, Gaynon P, Hann I, et al. CNS-directed therapy for childhood actue lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. J Clin Oncol. 2003;21:1798-1809.
41. Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol. 2000;109:13-23.
42. Pui CH. Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia. J Clin Oncol. 2003;21:179-181.
43. Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349:640-649.